Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-18-053878

Options or other derivatives

  • Director acquired 19,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Swirsky Douglas J Director 2018-10-12 Grant or award · Stock option (right to buy) +19,500 19,500 D
Loading xslF345X03/tv504843_form4.xml…